Sarah Rybowski currently serves as the Vice President of Global Medical Strategy, Scientific Communications, and Publications at Insmed Incorporated since March 2024. Prior to this role, Sarah Rybowski held significant positions at Eli Lilly and Company, including Head of Global/US Medical Affairs Oncology and US Medical Lead, where responsibilities included overseeing medical affairs for breast cancer and leading the US Medical Affairs Team. At Bayer Pharmaceuticals, Sarah Rybowski contributed to global strategies as the Global Real World Evidence Strategy Lead Oncology and provided strategic leadership as the Global Medical Director and Strategic Lead in Hematology, among other roles. Sarah Rybowski earned an MBBS (Hons), DFFP, and MRCGP (Dist) in Medicine from Imperial College London and attended Godolphin and Latymer for earlier education.
This person is not in the org chart
This person is not in any teams
This person is not in any offices